FDA Approves Anticounterfeiting Pigment
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has approved use of mica-based pearlescent pigments, commonly used in contact lenses, as color additives in ingested drugs
You may also be interested in...
Purdue Signs On To Market Labopharm's Once-Daily Tramadol
Labopharm will receive up to $170 mil. under the licensing deal, including $20 mil. up front and $40 mil. upon NDA approval.
Merck KGaA Boosts U.S. Generic Market Presence With Genpharm Expansion
Genpharm opens office in New York headed by former Able CEO Robert Mauro.
PhRMA DTC Principles Call For End Of Reminder Ads
Independent review panel will be established to handle complaints about pharmaceutical advertising.